ARYA Sciences Acquisition Corp III (ARYA) Stock Price, News & Analysis

Company Overview

ARYA Sciences Acquisition Corp III does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities in the healthcare industry. The company was incorporated in 2020 and is based in New York, New York.

Key Stats

• Today's Range: $10.77 to $11.25
• 50-Day Range: $9.91 to $11.16
• 52-Week Range: $9.82 to $25.89
• Volume: 366,228 shs
• Average Volume: 320,123 shs
• Market Capitalization: $186.48 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

ARYA Stock Analysis - Frequently Asked Questions

When did ARYA Sciences Acquisition Corp III IPO?

ARYA Sciences Acquisition Corp III (ARYA) raised $125 million in an IPO on Friday, August 7th 2020. The company issued 12,500,000 shares at a price of $10.00 per share. Jefferies and Goldman Sachs acted as the underwriters for the IPO.

What other stocks do shareholders of ARYA Sciences Acquisition Corp III own?

Based on aggregate information from My MarketBeat watchlists, some other companies that ARYA Sciences Acquisition Corp III investors own include Ampio Pharmaceuticals (AMPE), bluebird bio (BLUE), Forte Biosciences (FBRX), Navidea Biopharmaceuticals (NAVB), Outlook Therapeutics (OTLK), Electrameccanica Vehicles (SOLO) and Sequential Brands Group (SQBG).

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: N/A
• Industry: Holding & Other Investment Offices
• Sub-Industry: N/A
• Current Symbol: NASDAQ:ARYA
• CUSIP: N/A
• CIK: N/A
• Web: www.perceptivelife.com
• Phone: 212-284-2300
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.52
• Quick Ratio: 0.52

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.30 per share
• Price / Book: 37.20

Miscellaneous

• Outstanding Shares: 16,710,000
• Free Float: N/A
• Market Cap: $186.48 million
• Optionable: Not Optionable
• Beta: N/A